UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A longitudinal single-center cohort study on the prevalence and risk of accessory saphenous vein reflux after radiofrequency segmental thermal ablation of great saphenous veins

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2015-07, Vol.3 (3), p.265-269

2015

Volltextzugriff (PDF)

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Haematologica (Roma), 2011-01, Vol.96 (1), p.87-95

2011

Volltextzugriff (PDF)

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine

Clinical cancer research, 2011-12, Vol.17 (23), p.7240-7247

2011

Volltextzugriff (PDF)

A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre

Therapeutic advances in medical oncology, 2012-11, Vol.4 (6), p.289-293

2012

Volltextzugriff (PDF)

Metascoring and Gene Expression Profiling in Clinical Routine in Multiple Myeloma

Blood, 2011-11, Vol.118 (21), p.3940-3940

2011

Volltextzugriff (PDF)

Induction of angiogenesis by normal and malignant plasma cells

Blood, 2009-07, Vol.114 (1), p.128-143

2009

Volltextzugriff (PDF)

A Clinically Usable Gene Expression Report for Risk Assessment and Identification of Possible Therapeutic Targets in Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.1829-1829

2009

Volltextzugriff (PDF)

Inhibition of HIF1A Signaling by a Novel Class of Sulfonanilides for Targeted Treatment of Multiple Myeloma

Blood, 2009-11, Vol.114 (22), p.2856-2856

2009

Volltextzugriff (PDF)

A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma

Blood, 2008-11, Vol.112 (11), p.1667-1667

2008

Volltextzugriff (PDF)

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Blood, 2008-11, Vol.112 (11), p.248-248

2008

Volltextzugriff (PDF)

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Blood, 2008-11, Vol.112 (11), p.2701-2701

2008

Volltextzugriff (PDF)

Reply

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2016-07, Vol.4 (3), p.380-381

2016

Volltextzugriff (PDF)

A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood

Cancer research (Chicago, Ill.), 1995-09, Vol.55 (18), p.4065-4068

1995

Volltextzugriff (PDF)

Reply

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2016-07, Vol.4 (3), p.380

2016

Volltextzugriff (PDF)

Reply

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2016-07, Vol.4 (3), p.380-381

2016

Volltextzugriff (PDF)

Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy

Cancer research (Chicago, Ill.), 2003-07, Vol.63 (13), p.3483-3485

2003

Volltextzugriff (PDF)

Clonal and Subclonal Cytogenetic Aberrations: Association with D-Type Cyclin Expression and Event-Free Survival (EFS) in Multiple Myeloma (MM)

Blood, 2006-11, Vol.108 (11), p.3439-3439

2006

Volltextzugriff (PDF)

CD200 is a new prognostic factor in multiple myeloma

Blood, 2006-12, Vol.108 (13), p.4194-4197

2006

Volltextzugriff (PDF)

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Blood, 2009-04, Vol.113 (18), p.4331-4340

2009

Volltextzugriff (PDF)

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Oncogene, 2009-11, Vol.28 (44), p.3866-3879

2009

Volltextzugriff (PDF)

A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2018-01, Vol.6 (1), p.41-47.e1

2018

Volltextzugriff (PDF)

Reply

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2016, Vol.4 (3), p.380-381

2016

Volltextzugriff (PDF)

Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritis. Interstitial granulomatous dermatitis with arthritis

Journal der Deutschen Dermatologischen Gesellschaft, 2011-01, Vol.9 (1), p.67-69

2011

Volltextzugriff (PDF)

Inhibition of angiogenesis by non-toxic doses of temozolomide

Anti-cancer drugs, 2003-08, Vol.14 (7), p.515-522

2003

Volltextzugriff (PDF)

1 – 25 von 506

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(463)
Mit Volltextzugriff
(428)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(481)
Deutsch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A longitudinal single-center cohort study on the prevalence and risk of accessory saphenous vein reflux after radiofrequency segmental thermal ablation of great saphenous veins

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine

A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre

Metascoring and Gene Expression Profiling in Clinical Routine in Multiple Myeloma

Induction of angiogenesis by normal and malignant plasma cells

A Clinically Usable Gene Expression Report for Risk Assessment and Identification of Possible Therapeutic Targets in Multiple Myeloma

Inhibition of HIF1A Signaling by a Novel Class of Sulfonanilides for Targeted Treatment of Multiple Myeloma

A Gene Expression Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Bone Morphogenic Protein 6: A Prognostic Factor Expressed by Normal Plasma Cells and Multiple Myeloma Cells Inhibiting Their Proliferation and Angiogenesis Induction

Reply

A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood

Reply

Reply

Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy

Clonal and Subclonal Cytogenetic Aberrations: Association with D-Type Cyclin Expression and Event-Free Survival (EFS) in Multiple Myeloma (MM)

Angiogenesis in Multiple Myeloma (MM): Angiogenic Switch or Reflexion of Plasma Cell Number? A Gene Expression Based Survey in Primary Myeloma Cells and the Bone Marrow Microenvironment

CD200 is a new prognostic factor in multiple myeloma

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux

Reply

Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritis. Interstitial granulomatous dermatitis with arthritis

Inhibition of angiogenesis by non-toxic doses of temozolomide

Suchergebnisse filtern